Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy
NCT ID: NCT01994876
Last Updated: 2014-04-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2012-09-30
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Investigation Evaluating Three New 1-piece Ostomy Products
NCT03154944
Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis
NCT00144924
Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy.
NCT05923086
Closure of Anastomotic Leaks in the Stomach and Esophagus by Endoscopic Suturing
NCT01139424
Testing for Bacterial Contamination During Gastric Surgeries
NCT00417651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Coloplast Test 1
The subjects first test their own product to collect a baseline measurement
The subjects are randomised to first test Coloplast Test 1 and thereafter Coloplast Test 2
Coloplast Test 1
Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance
Coloplast Test 2
Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance
First Coloplast Test 2
The subjects first test their own product to collect baseline measurements
The subjects are randomised to first test Coloplast Test 2 and thereafter Coloplast Test 1
Coloplast Test 1
Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance
Coloplast Test 2
Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coloplast Test 1
Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance
Coloplast Test 2
Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Are at least 18 years of age and have full legal capacity
2. Have had an ileostomy for at least 3 months
3. Have used a convex ostomy appliance for the last month
4. Have given written informed consent
5. Have an ileostomy with a diameter of 33 mm or less
6. Have experience leakage (seeping) under the baseplate at least two times over the last two weeks
Exclusion Criteria
1. Have a loop ostomy (also called double-barrel or ostomy with two outlets)
2. Are pregnant or breastfeeding
3. Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy.
4. Currently receiving or have received, within the last month, systemic or local steroid treatment (adreno-cortical hormone) in the peristomal area
5. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin))
6. Are currently participating in another clinical investigation or has previously participated in this investigation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kalid S Abd-Elaziz, MD
Role: PRINCIPAL_INVESTIGATOR
QPS Holdings LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QPS
Groningen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP229
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.